Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.

Schoenfeld, D A; Finkelstein, D M; Richman, D D

Schoenfeld, D A; Finkelstein, D M; Richman, D D.

Affiliation

Schoenfeld DA; Biostatistics Center, Massachusetts General Hospital, Boston 02114.

AIDS ; 7(7): 955-8, 1993 Jul.

Article in En | MEDLINE | ID: mdl-8102853

Subject(s)

CD4-Positive T-Lymphocytes/cytology; Clinical Trials, Phase II as Topic/methods; HIV Infections/drug therapy; Research Design/standards; Zidovudine/therapeutic use; AIDS-Related Complex/drug therapy; Acquired Immunodeficiency Syndrome/drug therapy; Drug Therapy, Combination; Humans; T-Lymphocyte Subsets; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Research Design / CD4-Positive T-Lymphocytes / Zidovudine / HIV Infections / Clinical Trials, Phase II as Topic Type of study: Clinical_trials Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1993 Type: Article

Search on Google

XML

PubMed Links